Intention-to-treat analysis
Intention-to-treat analysis (ITT analysis) is a statistical approach used in randomized controlled trials. The ITT analysis includes every subject who is randomized according to randomized treatment assignment. It ignores noncompliance, protocol deviations, withdrawal, and anything that happens after randomization. ITT analysis is intended to avoid various misleading artifacts that can arise in intervention research such as non-random attrition of participants from the study or crossover.
History[edit]
The concept of ITT analysis was first introduced in the field of clinical trials in the 1970s. The principle behind this approach is to maintain the benefits of randomization, which is crucial in determining the efficacy of a treatment.
Principle[edit]
The principle of ITT analysis is that it includes all participants in the trial regardless of whether they completed or fully adhered to the treatment. This approach is based on the principle of randomization which assumes that every participant has an equal chance of being assigned to the treatment or control group.
Advantages[edit]
ITT analysis has several advantages. It preserves the random assignment of treatments, thus maintaining baseline comparability of treatment groups, and it reflects the pragmatic clinical question of the effect of treatment assignment, not of treatment completion.
Disadvantages[edit]
Despite its advantages, ITT analysis also has some limitations. It may underestimate the potential benefits of a treatment, as it includes participants who may not have fully adhered to the treatment. It also assumes that the reason for dropout is unrelated to the treatment, which may not always be the case.
Alternatives[edit]
Alternatives to ITT analysis include per-protocol analysis and as-treated analysis. Per-protocol analysis includes only those participants who completed the treatment originally allocated. As-treated analysis includes participants according to the treatment they actually received, rather than the one they were assigned to.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian